Package 27505-006-05

Brand: onapgo

Generic: apomorphine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 27505-006-05
Digits Only 2750500605
Product NDC 27505-006
Product ID 27505-006_4aa2a34c-370f-9da6-e063-6394a90ac79b
Description

5 CARTRIDGE in 1 CARTON (27505-006-05) / 20 mL in 1 CARTRIDGE (27505-006-01)

Marketing

Marketing Status
Marketed Since 2025-02-04
Brand onapgo
Generic apomorphine hydrochloride
Sample Package No

Linked Drug Pages (1)

ONAPGO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "4aa2a34c-370f-9da6-e063-6394a90ac79b", "openfda": {"unii": ["F39049Y068"], "rxcui": ["2705789", "2705796"], "spl_set_id": ["f3552b6e-5ae7-4993-aa1a-e399c4a7080a"], "manufacturer_name": ["MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 CARTRIDGE in 1 CARTON (27505-006-05)  / 20 mL in 1 CARTRIDGE (27505-006-01)", "package_ndc": "27505-006-05", "marketing_start_date": "20250204"}], "brand_name": "ONAPGO", "product_id": "27505-006_4aa2a34c-370f-9da6-e063-6394a90ac79b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Dopamine Agonists [MoA]", "Dopaminergic Agonist [EPC]"], "product_ndc": "27505-006", "generic_name": "Apomorphine hydrochloride", "labeler_name": "MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ONAPGO", "active_ingredients": [{"name": "APOMORPHINE HYDROCHLORIDE", "strength": "4.9 mg/mL"}], "application_number": "NDA214056", "marketing_category": "NDA", "marketing_start_date": "20250204", "listing_expiration_date": "20271231"}